Phospholipase A2 enzymes and the risk of atherosclerosis
European Heart Journal, 07/27/2012
Rosenson RS et al. – This article reviews the available experimental model and human trial evidence that serve as the basis for the development of these two classes of phospholipase A2 inhibitors.



